Loading
Search products, companies, tests, and guides — go from query to quote request in one place.
Tests
A proprietary chemiluminescent microparticle immunoassay (CMIA) used for the qualitative detection of IgG antibodies to SARS-CoV-2 in human serum and plasma on the Abbott ARCHITECT i system. The persistence of immunoglobulin class G (IgG) antibodies may identify people who have been infected in the past, recovered from the illness, and possibly developed immunity.
Company
Abbott Molecular Inc. is an IVD supplier based in United States, with a source-linked product portfolio. Molecular Assays. Coverage spans Instruments | qPCR.
Tests
A proprietary chemiluminescent microparticle immunoassay (CMIA) used for the qualitative detection of IgG antibodies to SARS-CoV-2 in human serum and plasma on the Abbott Alinity i system. The persistence of immunoglobulin class G (IgG) antibodies may identify people who have been infected in the past, recovered from the illness, and possibly developed immunity.
Tests
A proprietary chemiluminescent microparticle immunoassay (CMIA) used for the qualitative detection of IgM antibodies to SARS-CoV-2 in human serum and plasma on the Abbott Alinity i system. The presence of IgM antibodies may be associated with recent infection or may assist with the evaluation of disease course.
Tests
A chemiluminescent microparticle immunoassay (CMIA) used for the qualitative detection of IgM antibodies to SARS-CoV-2 in human serum and plasma on the Abbott ARCHITECT i system. The presence of IgM antibodies may be associated with recent infection or may assist with the evaluation of disease course.
Article
Research record from Eur J Clin Microbiol Infect Dis, 2026-09-09. PMID 42714826.
